Total Valuation
Medicalgorithmics SA has a market cap or net worth of zł280.67M. The enterprise value is zł300.25.
Market Capzł280.67M
Enterprise Valuezł300.25
Share Statistics
Medicalgorithmics SA has 9,952,769 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,952,769
Owned by Insiders―
Owned by Institutions0.09%
Financial Efficiency
Medicalgorithmics SA’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -11.38%.
Return on Equity (ROE)-0.18
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-11.38%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee284.27K
Profits Per Employee-107.19K
Employee Count109
Asset Turnover0.28
Inventory Turnover6.70
Valuation Ratios
The current PE Ratio of Medicalgorithmics SA is ―. Medicalgorithmics SA’s PEG ratio is 1.03.
PE Ratio―
PS Ratio10.79
PB Ratio5.18
Price to Fair Value5.18
Price to FCF-156.56
Price to Operating Cash Flow―
PEG Ratio1.03
Income Statement
In the last 12 months, Medicalgorithmics SA had revenue of 30.98M and earned -11.68M in profits. Earnings per share was -1.17.
Revenue30.98M
Gross Profit-5.56M
Operating Income-11.47M
Pretax Income-11.70M
Net Income-11.68M
EBITDA-6.83M
Earnings Per Share (EPS)-1.17
Cash Flow
In the last 12 months, operating cash flow was -1.82M and capital expenditures -3.36M, giving a free cash flow of -5.18M billion.
Operating Cash Flow-1.82M
Free Cash Flow-5.18M
Free Cash Flow per Share-0.52
Dividends & Yields
Medicalgorithmics SA pays an annual dividend of zł1.42, resulting in a dividend yield of ―
Dividend Per Sharezł1.42
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.93
52-Week Price Change-21.12%
50-Day Moving Average27.10
200-Day Moving Average29.73
Relative Strength Index (RSI)57.54
Average Volume (3m)43.70K
Important Dates
Medicalgorithmics SA upcoming earnings date is Sep 29, 2026, TBA (Confirmed).
Last Earnings DateMay 28, 2026
Next Earnings DateSep 29, 2026
Ex-Dividend Date―
Financial Position
Medicalgorithmics SA as a current ratio of 1.30, with Debt / Equity ratio of ―
Current Ratio1.30
Quick Ratio0.88
Debt to Market Cap0.07
Net Debt to EBITDA-2.90
Interest Coverage Ratio-5.60
Taxes
In the past 12 months, Medicalgorithmics SA has paid -23.00K in taxes.
Income Tax-23.00K
Effective Tax Rate<0.01
Enterprise Valuation
Medicalgorithmics SA EV to EBITDA ratio is -51.87, with an EV/FCF ratio of -165.85.
EV to Sales11.43
EV to EBITDA-51.87
EV to Free Cash Flow-165.85
EV to Operating Cash Flow-194.43
Balance Sheet
Medicalgorithmics SA has zł2.73M in cash and marketable securities with zł25.61M in debt, giving a net cash position of -zł19.83M billion.
Cash & Marketable Securitieszł2.73M
Total Debtzł25.61M
Net Cash-zł19.83M
Net Cash Per Share-zł1.99
Tangible Book Value Per Share-zł2.28
Margins
Gross margin is ―, with operating margin of -37.02%, and net profit margin of -37.71%.
Gross Margin―
Operating Margin-37.02%
Pretax Margin-37.76%
Net Profit Margin-37.71%
EBITDA Margin-22.04%
EBIT Margin-37.02%
Analyst Forecast
The average price target for Medicalgorithmics SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast45.02%
EPS Growth Forecast40.80%